• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15923 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 HAYES, Inc. Minimally invasive lumbar decompression (mild; Vertos Medical Inc.) for lumbar spinal stenosis
2012 HAYES, Inc. Outpatient cervical traction for treatment of neck pain
2012 HAYES, Inc. Tearlab osmolarity system (TearLab Corp.) for diagnosis of dry eye disease
2012 HAYES, Inc. Third eye retroscope (Avantis Medical Systems Inc.) for aiding the colonoscopic detection of colorectal polyps and adenomas
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Belatacept (Nulojix®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine/rilpivirine/tenofovir (Eviplera®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Everolimus (Afinitor®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dihydroartemisinin/piperaquine phosphate (Eurartesim®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dexmedetomidine (Dexdor®)
2012 Agency for Healthcare Research and Quality (AHRQ) Methods for insulin delivery and glucose monitoring: comparative effectiveness
2012 Agency for Healthcare Research and Quality (AHRQ) Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness
2012 Agency for Healthcare Research and Quality (AHRQ) Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 report
2012 Agency for Healthcare Research and Quality (AHRQ) Venous thromboembolism prophylaxis in orthopedic surgery
2012 Agency for Healthcare Research and Quality (AHRQ) Antinuclear antibody, rheumatoid factor, and cyclic-citrullinated peptide tests for evaluating musculoskeletal complaints in children
2012 Agency for Healthcare Research and Quality (AHRQ) First- and second- generation antipsychotics for children and young adults
2012 Agency for Healthcare Research and Quality (AHRQ) Self-measured blood pressure monitoring: comparative effectiveness
2012 Agency for Healthcare Research and Quality (AHRQ) Noncyclic chronic pelvic pain therapies for women: comparative effectiveness
2012 Medical Advisory Secretariat (MAS) Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices: an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Chronic obstructive pulmonary disease (COPD) evidentiary framework
2012 Medical Advisory Secretariat (MAS) Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review
2012 Medical Advisory Secretariat (MAS) Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Community-based multidisciplinary care for patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Noninvasive positive pressure ventilation for acute respiratory failure patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Hospital-at-home programs for patients with acute exacerbations of chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Home telehealth for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Cost-effectiveness of interventions for chronic obstructive pulmonary disease (COPD) using an Ontario policy model
2012 Medical Advisory Secretariat (MAS) Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature
2012 Medical Advisory Secretariat (MAS) Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B)
2012 Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Multiple intravenous infusions. Phase 1b: practice and training scan
2012 Medical Advisory Secretariat (MAS) Epilepsy surgery: an evidence summary
2012 Medical Advisory Secretariat (MAS) Epilepsy care in Ontario: an economic analysis of increasing access to epilepsy surgery
2012 Medical Advisory Secretariat (MAS) Metal-on-metal hip resurfacing arthroplasty: an analysis of safety and revision rates
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-invasive bi-level positive airway pressure as a weaning respiratory intervention for adult patients who have received pre-hospital continuous positive airway pressure to manage acute conditions: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention in adults with mental health and substance use needs: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization equipment and requirements for endoscopy equipment: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Standard equipment for the usual care of bariatric patients: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Prevention strategies for substance misuse: a review of the clinical evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Mindfulness training for weight loss in obese adults: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Dexmedetomidine for adult patients undergoing surgery: a review of clinical efficacy and safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Topical oxygen treatment for wound healing: a review of clinical and cost-effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Assessment of high sensitivity cardiac troponin T assay for the rapid diagnosis of acute coronary syndrome and acute myocardial infarction in the emergency room: a review of the clinical and economic evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Influenza vaccination for prevention of cross-species infection: a review of the clinical evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Removable rigid dressings for leg amputation: a review of the clinical effectiveness, cost effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Retreatment, switching and extended therapy with boceprevir and telaprevir for chronic hepatitis C infection: a review of the clinical effectiveness and safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of anemia and neutropenia in patients with chronic hepatitis C infection treated with peginterferon-ribavirin based regimens with or without protease inhibitors: a review of the clinical evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Protease inhibitor use for chronic hepatitis C infection in special populations: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for krabbe leukodystrophy: a review of the clinical and cost effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation interventions for pregnant women and mothers of infants: a review of the clinical effectiveness, safety, and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Campus of care models for adults with disabilities and seniors: a review of clinical benefits and harms and cost-effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Lipid lowering agents for stroke prevention: a review of the clinical evidence, safety and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Dabigatran for stroke prevention in atrial fibrillation: a review of the evidence on safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Olopatadine for the treatment of allergic conjunctivitis: a review of the clinical efficacy, safety, and cost-effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnosis and treatment of pineal gland cysts: a review of the clinical effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Congestive heart failure follow-up models: a review of the clinical effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Double gloves for prevention of transmission of blood borne pathogens to patients: a review of the clinical evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Immune response to hepatitis B vaccination: a review of the clinical evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Medication reconciliation at discharge: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Day programming for post-traumatic stress disorder: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) AmniSure versus fern testing to assess the rupture of fetal membranes in pregnant women: a review of the comparative accuracy, cost-effectiveness, and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Procedure site bleeding complications following percutaneous coronary interventions or angioplasty: a review of clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Codeine and acetaminophen for pain relief: a review of the clinical efficacy and safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care testing: a review of systematic reviews on testing accuracy and cost-effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid management practices for the prevention of drug diversion and misuse: a review of the clinical evidence and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Abuse and misuse potential of pregabalin: a review of the clinical evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Periostat for periodontal disease: a review of the clinical effectiveness, cost effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic smoking cessation interventions for patients with cardiovascular conditions: a review of the safety and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid trial periods for management of chronic non-cancer pain: a review of clinical effectiveness, guidelines and recommendations
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Dental treatment to correct dental caries in patients undergoing surgery: a review of clinical evidence on safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Chlorhexidine gluconate (CHG) for suturing in the emergency room and perineal washing during vaginal deliveries: a review of safety, evidence-based guidelines and recommendations
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Dental x-rays and cancer: a review of the evidence on safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Composite resin and amalgam dental filling materials: a review of safety, clinical effectiveness and cost-effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for adult psychiatric inpatients: a review of clinical evidence and effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel, prasugrel and ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness, cost effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Negative pressure wound therapy for patients with diabetic foot ulcers and pressure ulcers: a review of the clinical effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Custom foot orthotics for adults with foot conditions: a review of the clinical and cost effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Routine dental care programs in long term care: a review of the clinical effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Hydroxocobalamin for cyanide poisoning in the pre-hospital setting: a review of the comparative clinical effectiveness and safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Denosumab and zoledronic acid for patients with postmenopausal osteoporosis: a review of the clinical effectiveness, safety, cost effectiveness, and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Telemetry devices to monitor cardiac patients: a review of the safety and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab versus methotrexate, etanercept, adalimumab, and ustekinumab for plaque psoriasis: a review of the comparative clinical efficacy, safety and cost effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Sterile pre-filled saline syringes for acute care patients: a review of clinical evidence, cost-effectiveness, evidence-based guidelines, and safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Modafinil for sleep disorders and fatigue secondary to multiple sclerosis: a review of the clinical efficacy and safety
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous immunotherapy for the treatment of allergies: a review of the clinical efficacy, safety and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Electrocardiograms versus x-rays for guided placement of central venous catheter tips: a review of clinical and cost-effectiveness
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Sodium chloride inhalation for the treatment of cystic fibrosis: a review of the clinical evidence, cost-effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Drug eluting stents in adults with acute coronary syndrome: a review of the clinical effectiveness, safety and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-alcohol hand sanitizers for non-healthcare personnel: a review of the clinical effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Adaptive servo ventilation versus continuous or bi-level positive airway pressure: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Electronic cigarettes: a review of the clinical evidence and safety